MedPath

Effects of combined aerobic-resistance exercise training on levels of Asprosin, CTRP1, and MG53 in men with diabetes

Phase 3
Recruiting
Conditions
Type 2 diabetes.
Diabetes mellitus due to underlying condition
Registration Number
IRCT20181006041252N15
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
25
Inclusion Criteria

Lack of cardiovascular, musculoskeletal, and metabolic disorders limiting exercise
Lack of high blood pressure
Lack of regular exercise activity in the last 6 months
Not receiving insulin
No smoking
Not having diabetic foot ulcers

Exclusion Criteria

Inability to perform exercises

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine the levels of Asprosin. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determine the levels of CTRP1. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.;Determine the levels of MG53. Timepoint: At the beginning of the study (before the intervention) and 12 weeks after the start of the training program. Method of measurement: Use of Luminescence quantitative and ELISA methods.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath